Lu J, Dong Q, Zhang S, Feng Y, Yang J, Zhao L. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling. Cancer Sci. 2023.
Jia B, Zhao C, Minagawa K, Shike H, Claxton DF, W Ehmann C, Rybka WB, Mineishi S, Wang M, Schell TD, et al. Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model. J Immunol. 2023.
Liu X, Ren F, Li S, Zhang N, Pu JJ, Zhang H, Xu Z, Tan Y, Chen X, Chang J, et al. Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome. Discov Oncol. 2023;14(1):115.
De León AGómez-, Demichelis-Gomez R, da Costa-Neto A, Gómez-Almaguer D, Rego EMagalhães. Acute myeloid leukemia: challenges for diagnosis and treatment in Latin America. Hematology. 2023;28(1):2158015.
Teshima K, Ikeda S, Abe K, Yamada M, Takahashi N. Acute Myeloid Leukemia Harboring the t(16;21)(p11;q22) Translocation Treated With Venetoclax Plus Azacitidine After Cord Blood Transplantation. Cureus. 2023;15(7):e42215.
Rajsri KSrinivasan, Roy N, Chakraborty S. Acute Myeloid Leukemia Stem Cells in Minimal/Measurable Residual Disease Detection. Cancers (Basel). 2023;15(10).
Gajendra S, Anupurba S, Gupta R, Mallick SR, Panda D, Thakral D, Gupta SKumar, Bakhshi S, Seth R, Rai S, et al. Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity. Int J Lab Hematol. 2023.
Huang L, Lyu Z, Yang H, Gu M, Jiao Y, Shi Y. Acute toxicities of intravenous, intraperitoneal, or intratumoral injection of natural killer cells in human pancreatic adenocarcinoma-bearing mice: Randomized study. Int Immunopharmacol. 2023;124(Pt A):110881.
Kuo J-Y, Yeh C-S, Wang S-M, Chen S-H, Wang J-R, Chen T-Y, Tsai H-P. Acyclovir-resistant HSV-1 isolates among immunocompromised patients in southern Taiwan: Low prevalence and novel mutations. J Med Virol. 2023;95(8):e28985.
Zhu W, Wei X, Fang M. Acyl-CoA Medium-Chain Synthetase-3 (ACSM3) Is Regulated by Insulin Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3) and Inhibits Proliferation, Motility and Stem Cell Properties of Breast Invasive Carcinoma. Ann Clin Lab Sci. 2023;53(4):539-547.
Xu W, Gao L, Li W, Wang J, Yue Y, Li X. The adaptation of bovine embryonic stem cells to the changes of feeder layers. In Vitro Cell Dev Biol Anim. 2023.
Acosta MESoto, Perea M, Ruiz AI, Hilal M, Albornoz PL, Isla MI. Adaptative Strategies in Species (Cactaceae) and the Presence of Ectomycorrhizae Associated with Survival in Arid Environments. Plants (Basel). 2023;12(15).
de Vries ISNaarmann, Gjerga E, Gandor CLA, Dieterich C. Adaptive Sampling for Nanopore direct RNA sequencing. RNA. 2023.
Brochier A, Hofmans M, Lambrecht S, Breughe P, Denys B, De Bruyne S, Buysse M, Vantilborgh A, Bonroy C. The added value of automated HPC count: detecting clinically important interferences on the flow cytometric CD34+ cell count. Clin Chem Lab Med. 2023.
Thin MZaw, Moore C, Snoeks T, Kalber T, Downward J, Behrens A. Addendum: Micro-CT acquisition and image processing to track and characterize pulmonary nodules in mice. Nat Protoc. 2023.
Voorhees PM, Sborov DW, Laubach J, Kaufman JL, Reeves B, Rodríguez C, Chari A, Silbermann R, Costa LJ, Anderson LD, et al. Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial. Lancet Haematol. 2023.
Fischer L, Jiang L, Bittenbring JThomas, Huebel K, Schmidt C, Duell J, Metzner B, Krauter J, Glass B, Huettmann A, et al. The addition of rituximab to chemotherapy improves overall survival in mantle cell lymphoma-a pooled trials analysis. Ann Hematol. 2023.
Cao X-Y, Chen J-Q, Wang H, Ma W, Liu W-W, Zhang F-F, Xue S, Dong L, Liu T, Zhao X-Z, et al. Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML. Ann Med. 2023;55(1):388-400.
Liu W, Konermann A, Guo T, Jäger A, Zhang L, Jin Y. Additional instruction of Canonical Wnt signaling differently modulates osteogenic differentiation of mesenchymal stem cells derived from bone marrow and from periodontal ligament under inflammatory conditions. Biochim Biophys Acta Gen Subj. 2023:130323.
Müller TR, Sekine T, Trubach D, Niessl J, Chen P, Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, et al. Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states. Sci Transl Med. 2023;15(704):eadg9452.
Chiu Y-C, Lin Y-H, Chen Y-W, Kuo T-Y, Shie M-Y. Additive manufacturing of barium-doped calcium silicate/poly-ε-caprolactone scaffolds to activate CaSR and AKT signalling and osteogenic differentiation of mesenchymal stem cells. J Mater Chem B. 2023.
Sun H, Li B. Addressing musculoskeletal diseases by exploring the potentials of stem cells and plant-derived chemicals. J Orthop Translat. 2023;39:A1-A2.
Parra AS, Moezzi CA, Johnston CA. Adducin facilitates phase separation and function of a conserved spindle orientation complex. Front Cell Dev Biol. 2023;11:1220529.
Oporto K, Radojkovic C, Mellisho EA, Zuñiga F, Ormazabal V, Guzmán-Gutiérrez E, Nova-Lamperti E, Rodríguez-Álvarez L, Aranda M, Escudero C, et al. Adenosine promoted angiogenesis mediated by the release of small extracellular vesicles from human endothelial progenitor cells. Microvasc Res. 2023:104498.
Mikdar M, Serra M, Colin E, Duval R, Gauthier E-F, Lamarre Y, Colin Y, Le Van Kim C, Peyrard T, Koehl B, et al. Adenosine signaling inhibits erythropoiesis and promotes myeloid differentiation. Haematologica. 2023.